$VRTX News
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 6:59 a.m. June 24, 2014 - Anna Prior
Vertex Pharmaceuticals' Kalydeco Remains in Focus in 2015 - Analyst Blog 4:00 p.m. Jan. 12, 2015 - Zacks.com
Digging Deeper: Outperforming Stocks In The Leading Health Care Sector 12:10 p.m. Jan. 12, 2015 - Seeking Alpha
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
Vertex Pharma To Start Next-Gen Cystic Fibrosis Drug Studies Earlier Than Expected 6:08 a.m. Jan. 12, 2015 - TheStreet.com
Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Jan. 9, 2015 - TheStreet.com
Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More 7:51 a.m. Jan. 9, 2015 - 247WallSt.com
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon 6:15 a.m. Jan. 8, 2015 - TheStreet.com
Wells Fargo Top Biotech Stocks for 2015 2:10 p.m. Jan. 7, 2015 - 247WallSt.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
J.P. Morgan Chimes In With Ratings On BioTech Stocks 11:46 a.m. Jan. 6, 2015 - GuruFocus.com
UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF Market 9:24 a.m. Jan. 6, 2015 - benzinga.com
BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies 6:11 p.m. Jan. 5, 2015 - benzinga.com
3 Stocks Pushing The Drugs Industry Lower 1:10 p.m. Jan. 5, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NLNK ACHN MNKD VRTX 1:30 p.m. Jan. 2, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN MNKD VRTX NLNK 9:45 a.m. Jan. 2, 2015 - InvestorPlace.com
5 Biotech Stocks With Big News Due In January 12:15 p.m. Dec. 31, 2014 - Investors Business Daily
Vertex Pharmaceuticals' Kalydeco Label Expanded in the U.S. - Analyst Blog 4:30 p.m. Dec. 30, 2014 - Zacks.com
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog 10:41 a.m. Dec. 30, 2014 - Zacks.com
FDA clears expanded label for Kalydeco 3:35 p.m. Dec. 29, 2014 - Seeking Alpha
Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma 8:55 a.m. Jan. 7, 2015 - PR Newswire - PRF
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results 4:02 p.m. Jan. 6, 2015 - BusinessWire - BZX
On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada 9:20 a.m. Dec. 30, 2014 - PR Newswire - PRF
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:11 p.m. Dec. 29, 2014 - BusinessWire - BZX
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer 9:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
MassMutual Announces the Election of Three Members to its Board of Directors 12:00 p.m. Dec. 10, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Twitter gives out 47% of its revenue in stock bonuses 12:51 p.m. Oct. 29, 2014 - Philip van Doorn
11 stocks rising the most as the market heads toward a correction 10:29 a.m. Oct. 15, 2014 - Philip van Doorn
Everything you need to know about investing you learned in grade school 2:09 p.m. Oct. 7, 2014 - Tomi Kilgore
S&P, Nasdaq violate major support 9:02 a.m. Oct. 1, 2014 - Michael Ashbaugh
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
Oracle falls on earnings, Ellison move; Alibaba soars on debut 3:08 p.m. Sept. 19, 2014 - Sue Chang
Vertex Pharmaceuticals shares jump 4.9%, pace S&P 500 advancers 8:59 a.m. Sept. 5, 2014 - Tomi Kilgore
U.S. stocks push higher; biotechs rally 3:06 p.m. Aug. 13, 2014 - Anora Mahmudova
Vertex leads S&P 500, King drops on outlook 2:55 p.m. Aug. 13, 2014 - Sue Chang
10 stocks suffering the biggest cuts in earnings estimates 12:39 p.m. Aug. 11, 2014 - Philip van Doorn
Kinder Morgan soars, Tesla rallies on upgrade 11:46 a.m. Aug. 11, 2014 - Sue Chang
Mobileye rises for second day; Michael Kors falls 12:23 p.m. Aug. 4, 2014 - Sue Chang
Charting a slow-motion breakout attempt 10:08 a.m. July 23, 2014 - Michael Ashbaugh
U.S. stocks fall; Dow in triple-digit loss 3:36 p.m. June 24, 2014 - Anora Mahmudova
Dow falls over 100 points; energy stocks sell off: Stock market live blog recap 2:46 p.m. June 24, 2014 - blogs.marketwatch.com
Vertex soars on trial success; Best Buy gets buy rating 2:30 p.m. June 24, 2014 - Sue Chang
New studies bode well for Vertex's cystic fibrosis drug, analysts say 12:32 p.m. June 24, 2014 - Russ Britt
Vertex Pharmaceuticals shares skyrocket 50% 8:33 a.m. June 24, 2014 - Sue Chang
Vertex’ late-stage Cystic Fibrosis trial meets goals 6:59 a.m. June 24, 2014 - Anna Prior
Vertex Pharmaceuticals' Kalydeco Remains in Focus in 2015 - Analyst Blog 4:00 p.m. Jan. 12, 2015 - Zacks.com
Digging Deeper: Outperforming Stocks In The Leading Health Care Sector 12:10 p.m. Jan. 12, 2015 - Seeking Alpha
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
Vertex Pharma To Start Next-Gen Cystic Fibrosis Drug Studies Earlier Than Expected 6:08 a.m. Jan. 12, 2015 - TheStreet.com
Gilled Buying Vertex Among Bold Biotech Stock Predictions for 2015 10:42 a.m. Jan. 9, 2015 - TheStreet.com
Top Analyst Upgrades and Downgrades: Crocs, Halliburton, Nuance, Staples, Yelp and More 7:51 a.m. Jan. 9, 2015 - 247WallSt.com
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 1 1:09 p.m. Jan. 8, 2015 - TheStreet.com
Biogen Idec's Critical Nerve Repair Drug is Poised for Big News -- Soon 6:15 a.m. Jan. 8, 2015 - TheStreet.com
Wells Fargo Top Biotech Stocks for 2015 2:10 p.m. Jan. 7, 2015 - 247WallSt.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
J.P. Morgan Chimes In With Ratings On BioTech Stocks 11:46 a.m. Jan. 6, 2015 - GuruFocus.com
UPDATE: Barclays Capital Initiates Coverage On Vertex Pharmaceuticals On Leading Position In CF Market 9:24 a.m. Jan. 6, 2015 - benzinga.com
BTIG Initiates Coverage On Vertex Pharmaceuticals, Notes Company's Cystic Fibrosis Therapies 6:11 p.m. Jan. 5, 2015 - benzinga.com
3 Stocks Pushing The Drugs Industry Lower 1:10 p.m. Jan. 5, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NLNK ACHN MNKD VRTX 1:30 p.m. Jan. 2, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN MNKD VRTX NLNK 9:45 a.m. Jan. 2, 2015 - InvestorPlace.com
5 Biotech Stocks With Big News Due In January 12:15 p.m. Dec. 31, 2014 - Investors Business Daily
Vertex Pharmaceuticals' Kalydeco Label Expanded in the U.S. - Analyst Blog 4:30 p.m. Dec. 30, 2014 - Zacks.com
3 Biotech Stocks That Soared Past Gilead in 2014 - Analyst Blog 10:41 a.m. Dec. 30, 2014 - Zacks.com
FDA clears expanded label for Kalydeco 3:35 p.m. Dec. 29, 2014 - Seeking Alpha
Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma, Merrimack Pharma, Vertex Pharma, and Spectrum Pharma 8:55 a.m. Jan. 7, 2015 - PR Newswire - PRF
Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results 4:02 p.m. Jan. 6, 2015 - BusinessWire - BZX
On Winning Track: Complementary Research on Vertex, Ignyta, Novartis, Boeing and TransCanada 9:20 a.m. Dec. 30, 2014 - PR Newswire - PRF
U.S. Food and Drug Administration Approves KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:11 p.m. Dec. 29, 2014 - BusinessWire - BZX
David Altshuler, M.D., Ph.D., Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer 9:02 a.m. Dec. 15, 2014 - BusinessWire - BZX
MassMutual Announces the Election of Three Members to its Board of Directors 12:00 p.m. Dec. 10, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Vertex to Present at Deutsche Bank BioFEST on December 2 4:02 p.m. Nov. 20, 2014 - BusinessWire - BZX
Cystic Fibrosis Foundation Royalty Sale Will Be Transformational for People with CF 9:03 a.m. Nov. 19, 2014 - PR Newswire - PRF
Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation 7:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
Vertex to Present at the Credit Suisse Healthcare Conference on November 11 3:04 p.m. Oct. 30, 2014 - BusinessWire - BZX
Arrival of Former FDA Senior Officials Accelerates Greenleaf Expansion 7:00 a.m. Oct. 29, 2014 - BusinessWire - BZX
Vertex Reports Third Quarter 2014 Financial Results 3:04 p.m. Oct. 28, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 8:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation 3:47 p.m. Oct. 21, 2014 - BusinessWire - BZX
Vertex to Announce Third Quarter 2014 Financial Results on October 28 3:01 p.m. Oct. 14, 2014 - BusinessWire - BZX
Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis 8:32 a.m. Oct. 9, 2014 - BusinessWire - BZX
Senior Housing Properties Trust Announces LEED® Gold Certification of the Vertex Pharmaceuticals Biotech Buildings 7:02 a.m. Oct. 8, 2014 - BusinessWire - BZX
Regulatory Approvals, Lawsuits, Positive Study Results, Welfare Initiatives, and Technical Updates - Research Reports on Celgene, Actavis, Bristol-Myers Squibb, UnitedHealth and Vertex 8:20 a.m. Oct. 2, 2014 - PR Newswire - PRF
Analyst Scanner on Biotech Equities - Prana Biotechnology, CytRx, Insmed, Dynavax Technologies, and Vertex Pharma 8:15 a.m. Sept. 11, 2014 - PR Newswire - PRF
